Accuray Inc ARAY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
-
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
-
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
-
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
-
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
-
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation
Trading Information
- Previous Close Price
- $0.27
- Day Range
- $0.26–0.30
- 52-Week Range
- $0.22–2.10
- Bid/Ask
- $0.28 / $0.28
- Shares Outstanding
- 119.44M
- Market Cap
- $33.56M
- Volume/Avg
- 5M / 7M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.08
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 809
- Website
- https://www.accuray.com
Valuation
|
Metric
|
ARAY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.77 |
Price/Sales | 0.08 |
Price/Cash Flow | — |
Price/Earnings
ARAY
Financial Strength
|
Metric
|
ARAY
|
|---|---|
Quick Ratio | 0.68 |
Current Ratio | 1.50 |
Interest Coverage | −0.46 |
Quick Ratio
ARAY
Profitability
|
Metric
|
ARAY
|
|---|---|
Return on Assets (Normalized) | −7.24% |
Return on Equity (Normalized) | −58.60% |
Return on Invested Capital (Normalized) | −3.17% |
Return on Assets
ARAY
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|nNTW!F< | LOCK|<dkHN | $169B | |||
| Medtronic PLC
MDT
| LOCK|>&xQt^ | LOCK|>HK! | $110B | |||
| Stryker Corp
SYK
| LOCK|?$%mtc%H | LOCK|tL | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|wXN##% | LOCK|k?>& | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|W@R>?dr> | LOCK|&qlC | $49B | |||
| DexCom Inc
DXCM
| LOCK|l?r&@^R | LOCK|MCjZ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|QX$J?>W | LOCK|hr | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|NR& | LOCK|P> | $23B | |||
| Steris PLC
STE
| LOCK|&$H?>?! | LOCK|D!gzg | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|JwD<<L^ | LOCK|&xH | $17B |
United States